Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kan He

Showing results (161-170 of 188) with videos related to

Pageof 19
Sort By:
European Radiology|June 27, 2023
Radiomics nomogram for the prediction of microvascular invasion of HCC and patients' benefit from postoperative adjuvant TACE: a multi-center studyKun Zhang, Lei Zhang, Wen-Cui Li, et al.
Biology|October 25, 2024
MeHA: A Computational Framework in Revealing the Genetic Basis of Animal Mental Health Traits Under an Intensive Farming System-A Case Study in PigsJinyun Jiang, Lingyao Xu, Yizheng Zhuang, et al.
Frontiers in Psychiatry|November 12, 2021
Comorbidity and Treatment in Older Psychiatric In-patients-A Retrospective Study in a Chinese Psychiatric HospitalHongmei Liu, Yuncheng Zhu, Xiaohui Wu, et al.
Bioorganic & Medicinal Chemistry Letters|July 24, 2007
Enantiopure five-membered cyclicdiamine derivatives as potent and selective inhibitors of factor Xa. Improving in vitro metabolic stability via core modificationsJennifer X Qiao, Tammy C Wang, Gren Z Wang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 27, 2009
In vitro assessment of metabolic drug-drug interaction potential of apixaban through cytochrome P450 phenotyping, inhibition, and induction studiesLifei Wang, Donglu Zhang, Nirmala Raghavan, et al.
Bioorganic & Medicinal Chemistry Letters|June 22, 2014
Orally bioavailable factor Xa inhibitors containing alpha-substituted gem-dimethyl P4 moietiesMichael J Orwat, Jennifer X Qiao, Kan He, et al.
Bioorganic & Medicinal Chemistry Letters|June 14, 2008
Achieving structural diversity using the perpendicular conformation of alpha-substituted phenylcyclopropanes to mimic the bioactive conformation of ortho-substituted biphenyl P4 moieties: discovery of novel, highly potent inhibitors of Factor XaJennifer X Qiao, Daniel L Cheney, Richard S Alexander, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 5, 2011
Preclinical pharmacokinetics and pharmacodynamics of apixaban, a potent and selective factor Xa inhibitorKan He, Joseph M Luettgen, Donglu Zhang, et al.
Radiology|February 11, 2025
Gadoxetic Acid-enhanced MRI Scoring Model to Predict Pathologic Features of Hepatocellular CarcinomaKun Zhang, Kan He, Lei Zhang, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 21, 2015
Intravenous Clopidogrel (MDCO-157) Compared with Oral Clopidogrel: The Randomized Cross-Over AMPHORE StudyJean-Philippe Collet, Christian Funck-Brentano, Jayne Prats, et al.
Pageof 19

Showing results (161-170 of 188) with videos related to

Sort By:
Pageof 19
European Radiology|June 27, 2023
Radiomics nomogram for the prediction of microvascular invasion of HCC and patients' benefit from postoperative adjuvant TACE: a multi-center studyKun Zhang, Lei Zhang, Wen-Cui Li, et al.
Biology|October 25, 2024
MeHA: A Computational Framework in Revealing the Genetic Basis of Animal Mental Health Traits Under an Intensive Farming System-A Case Study in PigsJinyun Jiang, Lingyao Xu, Yizheng Zhuang, et al.
Frontiers in Psychiatry|November 12, 2021
Comorbidity and Treatment in Older Psychiatric In-patients-A Retrospective Study in a Chinese Psychiatric HospitalHongmei Liu, Yuncheng Zhu, Xiaohui Wu, et al.
Bioorganic & Medicinal Chemistry Letters|July 24, 2007
Enantiopure five-membered cyclicdiamine derivatives as potent and selective inhibitors of factor Xa. Improving in vitro metabolic stability via core modificationsJennifer X Qiao, Tammy C Wang, Gren Z Wang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 27, 2009
In vitro assessment of metabolic drug-drug interaction potential of apixaban through cytochrome P450 phenotyping, inhibition, and induction studiesLifei Wang, Donglu Zhang, Nirmala Raghavan, et al.
Bioorganic & Medicinal Chemistry Letters|June 22, 2014
Orally bioavailable factor Xa inhibitors containing alpha-substituted gem-dimethyl P4 moietiesMichael J Orwat, Jennifer X Qiao, Kan He, et al.
Bioorganic & Medicinal Chemistry Letters|June 14, 2008
Achieving structural diversity using the perpendicular conformation of alpha-substituted phenylcyclopropanes to mimic the bioactive conformation of ortho-substituted biphenyl P4 moieties: discovery of novel, highly potent inhibitors of Factor XaJennifer X Qiao, Daniel L Cheney, Richard S Alexander, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 5, 2011
Preclinical pharmacokinetics and pharmacodynamics of apixaban, a potent and selective factor Xa inhibitorKan He, Joseph M Luettgen, Donglu Zhang, et al.
Radiology|February 11, 2025
Gadoxetic Acid-enhanced MRI Scoring Model to Predict Pathologic Features of Hepatocellular CarcinomaKun Zhang, Kan He, Lei Zhang, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 21, 2015
Intravenous Clopidogrel (MDCO-157) Compared with Oral Clopidogrel: The Randomized Cross-Over AMPHORE StudyJean-Philippe Collet, Christian Funck-Brentano, Jayne Prats, et al.
Pageof 19